| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93e8f3f0e161df3d09d4b9a837a21e23 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-89 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-46 |
| filingDate |
2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab636f921f47a54fa1df651a56b39891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75d81941381a6b6bdcbf3386051286de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_619535b74a170f295393cb84baf3229b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9def40f1237f6f43f3e87c2d4ab29ac |
| publicationDate |
2013-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103189356-A |
| titleOfInvention |
N-heteroaryl compounds |
| abstract |
The present invention relates to certain N-heteroaryl compounds generally used as pharmaceuticals, more particularly as animal medicines. Said medicament can preferably be used in the treatment of helminth infections and in the treatment of parasitic diseases (as caused by helminth infections). The invention also relates to the use of said compounds in the manufacture of medicaments and methods of treatment comprising administering said compounds to an animal in need of said treatment. The invention also relates to novel N-heteroaryl compounds and the preparation of said compounds. Furthermore, the invention relates to pharmaceutical compositions and kits comprising said compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108368050-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110960485-A |
| priorityDate |
2010-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |